These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12946560)

  • 21. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
    Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
    Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
    Wang HL; Zhao Y; Xiang XH; Wang HS; Wu WR
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1079-87. PubMed ID: 15610920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats.
    Ayoub SM; Smoum R; Farag M; Atwal H; Collins SA; Rock EM; Limebeer CL; Piscitelli F; Iannotti FA; Lichtman AH; Leri F; Di Marzo V; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2020 Sep; 237(9):2753-2765. PubMed ID: 32556401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats.
    Wills KL; Vemuri K; Kalmar A; Lee A; Limebeer CL; Makriyannis A; Parker LA
    Psychopharmacology (Berl); 2014 Nov; 231(22):4291-300. PubMed ID: 24770676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague-Dawley rats.
    Petrie GN; Wills KL; Piscitelli F; Smoum R; Limebeer CL; Rock EM; Humphrey AE; Sheppard-Perkins M; Lichtman AH; Mechoulam R; Di Marzo V; Parker LA
    Psychopharmacology (Berl); 2019 Sep; 236(9):2623-2633. PubMed ID: 30993360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circadian rhythm influences naloxone induced morphine withdrawal and neuronal activity of lateral paragigantocellularis nucleus.
    Rahmati-Dehkordi F; Ghaemi-Jandabi M; Garmabi B; Semnanian S; Azizi H
    Behav Brain Res; 2021 Sep; 414():113450. PubMed ID: 34265318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precipitated and conditioned withdrawal in morphine-treated rats.
    Becker GL; Gerak LR; Li JX; Koek W; France CP
    Psychopharmacology (Berl); 2010 Mar; 209(1):85-94. PubMed ID: 20127077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats.
    Myers KM; Carlezon WA
    Biol Psychiatry; 2010 Jan; 67(1):85-7. PubMed ID: 19782965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extinction of conditioned opiate withdrawal in rats is blocked by intracerebroventricular infusion of an NMDA receptor antagonist.
    Coleman BR; Carlezon WA; Myers KM
    Neurosci Lett; 2013 Apr; 541():39-42. PubMed ID: 23416323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrete cues paired with naloxone-precipitated withdrawal from acute morphine dependence elicit conditioned withdrawal responses.
    Amitai N; Liu J; Schulteis G
    Behav Pharmacol; 2006 May; 17(3):213-22. PubMed ID: 16571999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conditioned aversive memory associated with morphine withdrawal increases brain-derived neurotrophic factor in dentate gyrus and basolateral amygdala.
    Martínez-Laorden E; Navarro-Zaragoza J; Milanés MV; Laorden ML; Almela P
    Addict Biol; 2020 Jul; 25(4):e12792. PubMed ID: 31282111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
    Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
    J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of inactivating the agranular or granular insular cortex on the acquisition of the morphine-induced conditioned place preference and naloxone-precipitated conditioned place aversion in rats.
    Li CL; Zhu N; Meng XL; Li YH; Sui N
    J Psychopharmacol; 2013 Sep; 27(9):837-44. PubMed ID: 23784741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine.
    Parke LA; Burton P; McDonald RV; Kim JA; Siegel S
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):293-7. PubMed ID: 11817506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local opioid withdrawal in rat single periaqueductal gray neurons in vitro.
    Chieng B; Christie MD
    J Neurosci; 1996 Nov; 16(22):7128-36. PubMed ID: 8929422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.
    Kawasaki Y; Jin C; Suemaru K; Kawasaki H; Shibata K; Choshi T; Hibino S; Gomita Y; Araki H
    Br J Pharmacol; 2005 Jul; 145(6):751-7. PubMed ID: 15880144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice.
    Maldonado C; Rodríguez-Arias M; Aguilar MA; Miñarro J
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):130-40. PubMed ID: 15179545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
    Ise Y; Narita M; Nagase H; Suzuki T
    Psychopharmacology (Berl); 2000 Jul; 151(1):49-54. PubMed ID: 10958116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of dopaminergic receptor signaling in the effects of glutamatergic receptor antagonists on conditioned place aversion induced by naloxone in single-dose morphine-treated rats.
    Kawasaki Y; Araki H; Suemaru K; Kitamura Y; Gomita Y; Sendo T
    J Pharmacol Sci; 2011; 117(1):27-33. PubMed ID: 21821972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-craving drugs acamprosate and naloxone do not reduce expression of morphine conditioned place preference in isolated and group-housed rats.
    Herzig V; Schmidt WJ
    Neurosci Lett; 2005 Feb; 374(2):119-23. PubMed ID: 15644276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.